Back to discover
Drug

Silver Compounds

Research stage
Emerging research
RxNorm1609278
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Silver Compounds
RxNorm CUI
1609278

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes3
Bismuth1Neurons1Sulfides1
Journals, researchers & institutions
Top journals
  • ACS applied materials & interfaces1
Leading researchers
  • Balamur R1
  • Hasanreisoglu M1
  • Kaleli HN1
  • Karatum O1
  • Konstantatos G1
  • Nizamoglu S1
  • Oh JT1
  • Onal A1
Leading institutions
free-text, unnormalised
  • ICFO-Institut de Ciencies Fotoniques1
  • Koç University1
  • Research Center for Translational Medicine1

Related drugs

2 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Bismuth

Frequently co-studied with Silver Compounds in the research literature.

1 shared paper
Silver

Frequently co-studied with Silver Compounds in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature